Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Evanescent waves in simulated ear canals: Experimental demonstration and method for compensation.

Siegel JH, Nørgaard KR, Neely ST.

J Acoust Soc Am. 2018 Oct;144(4):2135. doi: 10.1121/1.5058683.

PMID:
30404523
2.

The Relation Between White Matter Microstructure and Network Complexity: Implications for Processing Efficiency.

McDonough IM, Siegel JT.

Front Integr Neurosci. 2018 Sep 24;12:43. doi: 10.3389/fnint.2018.00043. eCollection 2018.

3.

Spectral Ripples in Round-Window Cochlear Microphonics: Evidence for Multiple Generation Mechanisms.

Charaziak KK, Siegel JH, Shera CA.

J Assoc Res Otolaryngol. 2018 Aug;19(4):401-419. doi: 10.1007/s10162-018-0668-6. Epub 2018 Jul 16.

PMID:
30014309
4.

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.

Vickers RJ, Tillotson GS, Nathan R, Hazan S, Pullman J, Lucasti C, Deck K, Yacyshyn B, Maliakkal B, Pesant Y, Tejura B, Roblin D, Gerding DN, Wilcox MH; CoDIFy study group.

Lancet Infect Dis. 2017 Jul;17(7):735-744. doi: 10.1016/S1473-3099(17)30235-9. Epub 2017 Apr 28.

5.

Differentiating Middle Ear and Medial Olivocochlear Effects on Transient-Evoked Otoacoustic Emissions.

Marks KL, Siegel JH.

J Assoc Res Otolaryngol. 2017 Aug;18(4):529-542. doi: 10.1007/s10162-017-0621-0. Epub 2017 Apr 21.

6.

Using Cochlear Microphonic Potentials to Localize Peripheral Hearing Loss.

Charaziak KK, Shera CA, Siegel JH.

Front Neurosci. 2017 Apr 4;11:169. doi: 10.3389/fnins.2017.00169. eCollection 2017.

7.

Identifying the Origin of Effects of Contralateral Noise on Transient Evoked Otoacoustic Emissions in Unanesthetized Mice.

Xu Y, Cheatham MA, Siegel JH.

J Assoc Res Otolaryngol. 2017 Aug;18(4):543-553. doi: 10.1007/s10162-017-0616-x. Epub 2017 Mar 16.

8.

Tuning of SFOAEs Evoked by Low-Frequency Tones Is Not Compatible with Localized Emission Generation.

Charaziak KK, Siegel JH.

J Assoc Res Otolaryngol. 2015 Jun;16(3):317-29. doi: 10.1007/s10162-015-0513-0. Epub 2015 Mar 27.

9.

Comparison of nine methods to estimate ear-canal stimulus levels.

Souza NN, Dhar S, Neely ST, Siegel JH.

J Acoust Soc Am. 2014 Oct;136(4):1768-87. doi: 10.1121/1.4894787.

10.

Exploration of stimulus-frequency otoacoustic emission suppression tuning in hearing-impaired listeners.

Charaziak KK, Souza PE, Siegel JH.

Int J Audiol. 2015 Feb;54(2):96-105. doi: 10.3109/14992027.2014.941074. Epub 2014 Oct 7.

11.

Estimating cochlear frequency selectivity with stimulus-frequency otoacoustic emissions in chinchillas.

Charaziak KK, Siegel JH.

J Assoc Res Otolaryngol. 2014 Dec;15(6):883-96. doi: 10.1007/s10162-014-0487-3. Epub 2014 Sep 18.

12.

Loss of the tectorial membrane protein CEACAM16 enhances spontaneous, stimulus-frequency, and transiently evoked otoacoustic emissions.

Cheatham MA, Goodyear RJ, Homma K, Legan PK, Korchagina J, Naskar S, Siegel JH, Dallos P, Zheng J, Richardson GP.

J Neurosci. 2014 Jul 30;34(31):10325-38. doi: 10.1523/JNEUROSCI.1256-14.2014.

13.

Characteristics of the 2f(1)-f(2) distortion product otoacoustic emission in a normal hearing population.

Poling GL, Siegel JH, Lee J, Lee J, Dhar S.

J Acoust Soc Am. 2014 Jan;135(1):287-99. doi: 10.1121/1.4845415.

14.

Stimulus-frequency otoacoustic emission suppression tuning in humans: comparison to behavioral tuning.

Charaziak KK, Souza P, Siegel JH.

J Assoc Res Otolaryngol. 2013 Dec;14(6):843-62. doi: 10.1007/s10162-013-0412-1. Epub 2013 Sep 7.

15.

Clinical Utilisation of High-frequency DPOAEs.

Poling G, Lee J, Siegel J, Dhar S.

ENT Audiol News. 2012 Sep-Oct;21(4):91-92.

16.

Behavioral hearing thresholds between 0.125 and 20 kHz using depth-compensated ear simulator calibration.

Lee J, Dhar S, Abel R, Banakis R, Grolley E, Lee J, Zecker S, Siegel J.

Ear Hear. 2012 May-Jun;33(3):315-29. doi: 10.1097/AUD.0b013e31823d7917.

17.

Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.

Thompson JA, Hamid O, Minor D, Amin A, Ron IG, Ridolfi R, Assi H, Berman D, Siegel J, Weber JS.

J Immunother. 2012 Jan;35(1):73-7. doi: 10.1097/CJI.0b013e31823735d6.

PMID:
22130164
18.

Time-efficient measures of auditory frequency selectivity.

Charaziak KK, Souza P, Siegel JH.

Int J Audiol. 2012 Apr;51(4):317-25. doi: 10.3109/14992027.2011.625982. Epub 2011 Nov 22.

19.

Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.

Weber JS, Amin A, Minor D, Siegel J, Berman D, O'Day SJ.

Melanoma Res. 2011 Dec;21(6):530-4. doi: 10.1097/CMR.0b013e32834d3d88.

PMID:
22051508
20.

Interaction of tamoxifen and noise-induced damage to the cochlea.

Pillai JA, Siegel JH.

Hear Res. 2011 Dec;282(1-2):161-6. doi: 10.1016/j.heares.2011.08.012. Epub 2011 Sep 2.

Supplemental Content

Loading ...
Support Center